PBAC wants COVID-19 antiviral prescribing rules tightened as cost reaches $1 billion
The PBAC has warned that the $981 million annual cost of subsiding COVID-19 antivirals must be curbed with stricter PBS criteria or price cuts for the manufacturers. …